The competent and effective management of the Australian Nuclear Science and Technology Organisation (ANSTO) has been reinforced following the appointment of Dr Susan Pond and the reappointment of Professor Paul Greenfield as part-time board members for four year terms.
Chairman of ANSTO’s Board, Dr Ziggy Switkowski, today announced that Dr Susan Pond, AM, FTSE has been appointed as the newest member of the ANSTO Board and that Professor Paul Greenfield has been reappointed for another term.
Dr Switkowski said Dr Pond’s scientific and business experience would be a great asset to the organisation.
“Dr Pond has a very distinguished career in scientific, medical, educational and commercial fields,” Dr Switkowski said. Her combination of clinical and scientific expertise combined with her strategic planning and commercial leadership make her a valuable addition to our Board.”
Until recently Dr Pond was a senior executive with Johnson & Johnson serving as both Director of Pharmaceutical Research and Managing Director of its Australian biotechnology company, where she was a strong driver of research collaboration programs. Dr Pond also served as Chair of AusBiotech.
Dr Pond has held senior professorial positions at the University of California, San Francisco and then the University of Queensland. She currently serves on the Board of Commercialisation Australia, the Board of ATSE and the Board of Governors of the Centenary Institute of Cancer Medicine and Cell Biology, Dr Switkowski also announced that Professor Paul Greenfield, AO, had been reappointed to the Board for another four-year term.
“Professor Greenfield is Vice-Chancellor and President of the University of Queensland. He has been a valuable ANSTO Board member for the past three years and has made important contributions in areas of strategy, project funding and management, research assessment and corporate governance.
“I congratulate Dr Pond and Professor Greenfield on their appointments. I look forward to their contributions to maintain and expand ANSTO’s reputation as a leading national laboratory and an internationally renowned centre for nuclear science and technology research,” Dr Switkowski concluded.
Published: 02/07/2010